HIV-AIDS

Rebecca Lynch, PhD, was awarded $3.6 million to investigate HIV-1 resistance to antibody treatments.

Research from the George Washington University has found that apolipoprotein A-I binding protein restricts HIV-1 replication by targeting lipid rafts and reducing virus-cell fusion.

A new review article from researchers at the GW School of Medicine and Health Sciences provides an extensive characterization of state-of-the-art uses for toll-like receptors in HIV eradication.

A research team including Michael Bukrinsky, MD, PhD, from the GW School of Medicine and Health Sciences published in PLOS Pathogens on the role of an HIV protein in causing metabolic comorbidities.

The AIDS and Cancer Specimen Resource has been renewed for five years with GW serving as the primary site.

Lawrence “Bopper” Deyton, MD ’85, MSPH, senior associate dean for clinical public health and Murdock Head Professor of Medicine and Health Policy, spoke to The Atlantic for an article on Whitman-Walker and the AIDS epidemic in Washington, D.C.

Researchers from the GW School of Medicine and Health Sciences received more than $3.1 million from the National Institutes of Health to investigate the causes of cardiovascular disease in HIV-infected patients

Maureen Lyon, PhD, professor of pediatrics, spoke to MD Magazine for an article discussing her recent study on the impacts of advance care planning on HIV symptoms in teens.

Susan LeLacheur, DrPH ’08, MPH ’89, PA-C, BS ’82, associate professor of physician assistant studies at SMHS, received the Master Faculty Award at the 2018 Physician Assistant Education Association Education Forum.

The GW School of Medicine and Health Sciences is one of only two sites chosen for the first clinical trial of a HIV vaccine candidate.